Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma
Cancer Immunology, Immunotherapy · 2023
DOI: 10.1007/s00262-023-03369-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2023. Verfasst von Tadatsugu Anno und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, Kobayashi Foundation for Cancer Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
- Department of Urology, Keio University School of Medicine, Tokyo, 160-8582, Japan. urotanaka@keio.jp.
- Department of Diagnostic Pathology, Keio University Hospital, Tokyo, 160-8582, Japan.
- Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Förderung
- Japan Society for the Promotion of Science
- Takeda Science Foundation
- Kobayashi Foundation for Cancer Research
- SGH Foundation for Cancer Research
- Keio Gijuku Academic Development Funds
- Princess Takamatsu Cancer Research Fund
Zitieren
APA
Anno, T., Tanaka, N., Takamatsu, K., Hakozaki, K., Kufukihara, R., Baba, Y., Takeda, T., Matsumoto, K., Morita, S., Kosaka, T., Mikami, S., Nishihara, H., Mizuno, R., & Oya, M. (2023). Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-023-03369-8
Vancouver
Anno T, Tanaka N, Takamatsu K, Hakozaki K, Kufukihara R, Baba Y, et al. Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma. Cancer Immunology, Immunotherapy. 2023. doi:10.1007/s00262-023-03369-8
BibTeX
@article{Anno2023,
author = {Anno, Tadatsugu and Tanaka, Nobuyuki and Takamatsu, Kimiharu and Hakozaki, Kyohei and Kufukihara, Ryohei and Baba, Yuto and Takeda, Toshikazu and Matsumoto, Kazuhiro and Morita, Shinya and Kosaka, Takeo and Mikami, Shuji and Nishihara, Hiroshi and Mizuno, Ryuichi and Oya, Mototsugu},
title = {Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2023},
doi = {10.1007/s00262-023-03369-8}
}
EUVIMED